NTELOS Holdings Corp (NTLS) is Trading Lower on Unusual Volume for January 15

Equities Staff |

NTELOS Holdings Corp (NTLS) experienced unusually high volume on Jan. 15, as the stock lost 0.49% to a closing price of $9.17. The stock saw 467,200 shares trade hands over the course of the day on 1,581 trades. Given that the stock’s average daily volume over the last month has been 248,013 shares a day, this represents a pretty substantial spike over the norm.

NTELOS Holdings Corp has a P/B ratio of -8.65. The stock has traded between $9.35 and $3.85 over the last 52-weeks, its 50-day SMA is now $9.15, and its 200-day SMA $7.76.

NTELOS Holdings Corp is a provider of digital wireless communications services to consumers and businesses. It offers wireless voice and CDMA digital data PCS products and services to retail and business customers.

Headquartered in Waynesboro, VA, NTELOS Holdings Corp has 854 employees and is currently under the leadership of CEO Rodney D. Dir.

For a complete fundamental analysis analysis of NTELOS Holdings Corp, check out Equities.com’s Stock Valuation Analysis report for NTLS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…